We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Getinge AB (GETI B) Ser B Npv

Sell:185.70 SEK Buy:185.85 SEK Change: 5.70 SEK (2.98%)
Market closed |  Prices as at close on 15 July 2024 | Switch to live prices |
Sell:185.70 SEK
Buy:185.85 SEK
Change: 5.70 SEK (2.98%)
Market closed |  Prices as at close on 15 July 2024 | Switch to live prices |
Sell:185.70 SEK
Buy:185.85 SEK
Change: 5.70 SEK (2.98%)
Market closed |  Prices as at close on 15 July 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Getinge AB is a Sweden-based company operating within healthcare sector. The Company provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.

Contact details

Lindholmspiren 7,
P.O. Box 8861
417 56
+46 (3) 5155500

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
48.64 billion SEK
Shares in issue:
272.37 million
Health Care Equipment
Stockholm Stock Exchange
Swedish Krona
OMX Stockholm 30

Key personnel

  • Mattias Perjos
    President, Chief Executive Officer, Director
  • Agneta Palmer
    Chief Financial Officer
  • Elin Frostehav
    President - Acute Care Therapies
  • Eric Honroth
    President - Life Science
  • Stephane Le Roy
    President - Surgical Workflows
  • Magnus Lundbaeck
    Chief Human Resource Officer, Executive Vice President
  • Joanna Engelke
    Executive Vice President - Quality Compliance, Regulatory and Medical Affairs
  • Anna Romberg
    Executive Vice President - Sustainability, Legal & Compliance
  • Carsten Blecker
    Chief Commercial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.